TNFSF10 and hematologic disorder: We demonstrated that LUV-TRAIL are more effective than soluble recombinant TRAIL (sTRAIL), inducing apoptosis both in vitro and in vivo in hematological malignancies [19,20,21] as well as in epithelial-derived cancers [22,23,24].